EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Artificial intelligence empowering precision oncology: The convergence and innovation of traditional Chinese medicine and Western medicine wisdom

Chang Qiao, Yu-Tong Han, Jiang-Ping Zhan, Jia Yuan, Xiao-Tong Tian, Yue-Chuan Jiao, Hao-Wei Li, Ling-Yong Wu, Chu Li, Yu-Xuan He, De-Hui Li

Artificial Intelligence in Cancer · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

The prevention and treatment of malignant tumors remain a major global health challenge. Owing to the marked heterogeneity and dynamic evolution of cancer, conventional diagnostic and therapeutic paradigms are increasingly inadequate for the demands of precision medicine. Artificial intelligence (AI) is accelerating the transition of comprehensive cancer care from experience-driven practice toward data-driven, dynamically supported decision-making. By leveraging machine learning, deep learning, natural language processing, knowledge graphs, graph neural networks, and multimodal data fusion, AI has been widely applied across key domains of oncology, including cancer screening, medical image interpretation, digital pathology analysis, molecular subtyping, treatment response assessment, and prognostic prediction. These advances provide new technical pathways for individualized diagnosis and treatment as well as whole-course disease management. At the same time, traditional Chinese medicine (TCM), with its holistic view and treatment based on syndrome differentiation, offers unique theoretical and practical advantages in comprehensive cancer prevention and treatment. However, modern TCM research has long been constrained by the limited objectification of syndromes, substantial heterogeneity in clinical data, complex mechanisms underlying the actions of Chinese herbs, and the lack of standardized evaluation systems. In recent years, AI has been increasingly applied in TCM research, including knowledge mining from classical medical texts and clinical records, syndrome identification, analysis of herbal compatibility rules, screening of active constituents, prediction of therapeutic targets, and construction of efficacy evaluation models. These developments provide a novel methodological foundation for integrating TCM with modern precision oncology. Against this background, this review systematically summarizes the integration pathways, application value, and practical challenges of AI in integrated TCM and Western medicine for cancer treatment, with the aim of providing a theoretical basis and practical reference for the development of intelligent integrated precision oncology.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Chang Qiao, Yu-Tong Han, Jiang-Ping Zhan, Jia Yuan, Xiao-Tong Tian, Yue-Chuan Jiao, Hao-Wei Li, Ling-Yong Wu, Chu Li, Yu-Xuan He, De-Hui Li
Quelle
Artificial Intelligence in Cancer
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
2644-3228
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Chang Qiao, Yu-Tong Han, Jiang-Ping Zhan, Jia Yuan, Xiao-Tong Tian, Yue-Chuan Jiao, Hao-Wei Li, Ling-Yong Wu, Chu Li, Yu-Xuan He, De-Hui Li (2026). Artificial intelligence empowering precision oncology: The convergence and innovation of traditional Chinese medicine and Western medicine wisdom. Artificial Intelligence in Cancer. https://doi.org/10.35713/aic.121344
RIS BibTeX CSL-JSON